Covered recipient · General Payments record
ASAAD ELBASHIR
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$1,986.57
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $578.65 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $161.43 | 3 |
| SANOFI-AVENTIS U.S. LLC | $138.37 | 3 |
| Novo Nordisk AS | $71.12 | 3 |
| Kyowa Kirin, Inc. | $65.52 | 3 |
| TOLMAR, INC. | $51.24 | 2 |
| BETA BIONICS, INC. | $39.37 | 1 |
| Xeris Pharmaceuticals, Inc. | $22.79 | 1 |
| ABBVIE INC. | $15.47 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.47 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103684003 | CMS |
| BETA BIONICS, INC. | $39.37 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087885351 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $13.34 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144443298 | CMS |
| Dexcom, Inc. | $111.88 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153283394 | CMS |
| Dexcom, Inc. | $25.48 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153283398 | CMS |
| Dexcom, Inc. | $24.07 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153283402 | CMS |
| Kyowa Kirin, Inc. | $24.30 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127025826 | CMS |
| Kyowa Kirin, Inc. | $21.57 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127025828 | CMS |
| Kyowa Kirin, Inc. | $19.65 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127025830 | CMS |
| Novo Nordisk Inc | $19.73 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096843981 | CMS |
| Novo Nordisk Inc | $26.36 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097543148 | CMS |
| Novo Nordisk Inc | $25.03 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096941146 | CMS |
| SANOFI-AVENTIS U.S. LLC | $4.97 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139906070 | CMS |
| SANOFI-AVENTIS U.S. LLC | $125.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139906126 | CMS |
| SANOFI-AVENTIS U.S. LLC | $8.40 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139906130 | CMS |
| Tolmar, Inc. | $28.92 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138712208 | CMS |
| Tolmar, Inc. | $22.32 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138711100 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.79 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144587704 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.